Finland· FI-REL-REL61812
Linagliptin/Metformin Sandoz
A metformin and linagliptin product containing linagliptin + metformin hydrochloride, registered in Finland by Sandoz A/S. The same ATC class is registered in 13 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Metformin and linagliptin is registered in 13 of 19 countries.
Countries holding a registration under ATC A10BD11 (metformin and linagliptin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Metformin and linagliptin · ATC A10BD11
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Linagliptin + Metformin hydrochloride
- Manufacturer
- Sandoz A/S
- Country
- Finland (FI)
- ATC code
- A10BD11
- ATC class
- Metformin and linagliptin
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for metformin and linagliptin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metformin and linagliptin · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Metformin and linagliptin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaJENTADUETOBoehringer Ingelheim International GmbH, Ingelheim am Rhein
- SpainJENTADUETO 2,5 MG/ 1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULABoehringer Ingelheim International Gmbh
- United StatesJentaduetoBoehringer Ingelheim Pharmaceuticals, Inc.
- SwitzerlandJentadueto
- PolandAutnamiSandoz Polska Sp. z o.o.
- United KingdomJentadueto 2.5mg/1000mg tabletsCST Pharma Ltd
- IrelandJentadueto 2.5 mg/1000 mg film-coated tabletsBoehringer Ingelheim International GmbH
- NetherlandsJentadueto 2,5 mg/1000 mg filmomhulde tablettenBoehringer Ingelheim International GmbH
Authorised across Europe · EMA
The same active substance is authorised in 24 EEA countries. Names it is sold under:
- Austria · Ilinpru Combi, Linagliptin/Metformin
- Bulgaria · Ilinpru Combi, Linatin Met
- Cyprus · Autnami, Linagliptin/Metformin Tad
- Czechia · Linagliptin/Metformin Sandoz, Linagliptin/Metformin Stada
- Denmark · Glymetia, Liglifev
- Estonia · Autnami, Linagliptin/Metformin Stada
- Spain · Linagliptina/Metformina Cinfa, Linagliptina/Metformina Combix
- United Kingdom (Northern Ireland) · Linagliptin/ Metformin Hydrochloride Torrent Pharma (Uk), Linagliptin/Metformin Hydrochloride Zentiva Pharma Uk
- Greece · Alfalib, Linagliptin+metformin Stada
- Croatia · Autnami, Lymerexo
- Hungary · Autnami, Ilinpru Combi
- Ireland · Linagliptin/Metformin Hydrochloride Rowex
- Iceland · Jentadueto
- Italy · Linagliptin E Metformina Eg, Linagliptin E Metformina Sandoz
- Liechtenstein · Jentadueto
- Lithuania · Autnami, Linagliptin/Metformin Stada
- Latvia · Autnami, Linagliptin/Metformin Stada
- Malta · Glymetia, Linagliptin/Metformin Clonmel
- Netherlands · Liglifev
- Norway · Jentadueto
- Poland · Autnami, Linagliptin + Metformin Hydrochloride Stada
- Portugal · Metformina + Linagliptina Alter, Metformina + Linagliptina Krka
- Slovenia · Liglipexcombi, Linagliptin/Metformin Krka
- Slovakia · Linagliptin/Metformin Sandoz, Linagliptin/Metformin Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cc17481d-d4e7-4e99-a773-5a7980dd1554 GET /v1/drugs/cc17481d-d4e7-4e99-a773-5a7980dd1554?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "2",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "ED",
"strength": "2.5 mg / 850 mg",
"atc_label": "metformiini ja linagliptiini",
"ma_number": "42747",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL61812",
"authorised_at": "2024-09-27"
}See everything about metformin and linagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.